Cagrilinitide has been designed to replicate the bioactive regions of GLP-1 and GIP, thereby enabling it to bind to the receptors for these hormones and elicit similar effects. Through the manipulation of specific amino acids, Cagrilinitide can activate the receptors involved in insulin secretion, appetite regulation, and glucose metabolism, and has shown potential in improving body composition by targeting fat loss rather than lean muscle mass.
- Weight Loss and Appetite Suppression
- Improve Body Composition
- Promote Insulin Secretion and Improve Glucose Metabolism
- Contribute to Overall Cardiovascular Health due to effects on Insulin and Glucose
Cagrilinitide is often paired with a GLP, GLP-1 or GIP Agonist.
Vial contains lyophilized product. Reconstitution solution of choice must be added before use.
Reviews
There are no reviews yet.